Human medicines European public assessment report (EPAR): Fulphila, pegfilgrastim, Date of authorisation: 20/11/2018, Revision: 14, Status: Authorised

14 August 2026

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 18, Status: Authorised

14 August 2026

Scientific publications

14 August 2026

Artificial intelligence

14 August 2026

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 6, Status: Authorised

14 August 2026

European Medicines Agency’s data protection notice on 360 assessment

14 August 2026

EMA multi-stakeholder workshop on supporting innovation in cardiovascular medicines and medical devices in the EU, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2026, 13:00 (CEST) to 2 July 2026, 16:00 (CEST)

14 August 2026

Presentation - AI and digital technologies transforming cardiovascular device in novation (S. Zenker)

14 August 2026

Presentation - Artificial intelligence for drug development in cardiovascular medicine (C. Mittman)

14 August 2026

Presentation - AI in cardiovascular care (F. Asselbergs)

14 August 2026